Max Healthcare Institute Ltd. (MAXHEALTH) 52 Week Low Streak: Eighth Straight Session Near Trough

Max Healthcare Institute Ltd. has now traded within 2% of its 52-week low for its eighth consecutive session, and the move across that stretch is down 9.91%. The latest reading places MAXHEALTH in the same yearly low zone again, with the stock last trading at Rs 886.4 against a 52-week low area that remains under pressure. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline.

At 12 October 2026 at 9:23 AM IST, MAXHEALTH was trading at Rs 886.4 versus the previous close of Rs 884, after opening at Rs 883.75 and touching a high and low of Rs 894.4 and Rs 883.75 respectively. The company’s market capitalisation stood at Rs 86,040.63 crore. For a reader, the repeated-low pattern matters more than a one-line intraday move because it shows sustained pressure near the trough rather than a one-off dip.

Max Healthcare Institute Ltd. 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 886.4
Previous Close	Rs 884
Today's Move	+Rs 2.4 (+0.27%)
Open	Rs 883.75
High	Rs 894.4
Low	Rs 883.75
Market Capitalisation	Rs 86,040.63 crore

Max Healthcare Institute Ltd. (MAXHEALTH) traded at Rs 886.4 versus the previous close of Rs 884, a rise of 0.27%. The stock opened at Rs 883.75, reached a high of Rs 894.4, touched a low of Rs 883.75.

MAXHEALTH Share Price Today remained close to the lower end of the day’s range, even though the stock was modestly above the previous close. The share price was at Rs 886.4, up Rs 2.4 or 0.27% from the previous close of Rs 884. The day opened at Rs 883.75 and the same level also marked the low, while the high of Rs 894.4 kept the move contained within a narrow band. That range matters because it shows the stock is still being priced close to the repeated low zone rather than moving away from it.

The current pattern places MAXHEALTH Share Price in a wider decline context, not a one-session event. MAXHEALTH Stock News over the last several sessions has therefore centred on the fact that the stock continues to trade near its yearly low zone. In a market update like this, the relevant reading is not the small positive intraday change by itself, but the way MAXHEALTH Share Price has stayed pinned near the 52-week trough for an extended stretch. The market capitalisation of Rs 86,040.63 crore also shows that this is a large listed healthcare franchise, so repeated weakness in MAXHEALTH Share Price Today is being watched closely by market participants tracking Indian healthcare stocks.

What the Repeated 52-Week Lows Show

The key point in the MAXHEALTH 52 Week Low Streak is that the stock has now spent eight straight sessions trading within 2% of its 52-week low. That repeated pattern is more informative than a single-day low because it points to a persistent price zone that the market has not meaningfully moved away from. The cumulative move across the streak is down 9.91%, which makes the MAXHEALTH 52 Week Low For eighth consecutive session narrative important for readers tracking the stock’s stock performance.

Another useful detail is how the current low zone compares with the prior event date. The previous event trading date was 2026-10-09, which shows that the repeated weakness has continued without a material reset in sentiment. MAXHEALTH New One Year Low coverage often focuses on a one-day print, but the MAXHEALTH Back To Back 52 Week Lows pattern is different because it reflects a drawn-out low zone. The latest Univest reading confirms the price pattern, but it does not establish a company-specific trigger behind the continued move.

For investors screening Stocks Hitting 52 Week Lows, this is the kind of setup that usually deserves follow-up rather than a quick conclusion. MAXHEALTH Consecutive 52 Week Low behaviour tells readers that the stock is not merely touching the lower edge of its range once; it is repeatedly spending time there. That makes MAXHEALTH Share Price a useful watchlist item for anyone scanning Stocks At One Year Low Today or building a broader view of 52 Week Low Stocks.

Max Healthcare Institute Ltd. (MAXHEALTH) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 86,040.63 crore
P/E Ratio	59.06x
P/B Ratio	7.87x
ROE	14.53%
ROCE	14.97%
EPS	Rs 14.97
Book Value Per Share	Rs 112.27
Dividend Yield	0.23%

Max Healthcare Institute Ltd. (MAXHEALTH) fundamental metrics show P/E 59.06x, P/B 7.87x, ROE 14.53%, ROCE 14.97%. These figures provide context only and are not a buy or sell signal.

Max Healthcare Institute Ltd. has a market capitalisation of Rs 86,040.63 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 59.06x, P/B at 7.87x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.53% and ROCE of 14.97%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 14.97, book value per share of Rs 112.27, dividend yield of 0.23%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 38.95x, median ROE of 12.77%, median ROCE of 15.77%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	59.06x
Benchmark Median P/E	38.95x
Benchmark Average P/E	86.13x
Benchmark P/E Range	0x to 1,589.53x
Company P/B Ratio	7.87x
Benchmark Median P/B	3.27x
Company ROE	14.53%
Benchmark Median ROE	12.77%
Company ROCE	14.97%
Benchmark Median ROCE	15.77%
Company Market Capitalisation	Rs 86,040.63 crore
Benchmark Median Market Cap	Rs 449.19 crore

Max Healthcare Institute Ltd. (MAXHEALTH) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

Max Healthcare Institute Ltd. (MAXHEALTH) has a P/E ratio of 59.06x, which is above the benchmark median of 38.95x, a difference of +51.63%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Max Healthcare Institute Ltd. (MAXHEALTH) has a ROE of 14.53%, which is above the benchmark median of 12.77%, a difference of +13.78%. Max Healthcare Institute Ltd. (MAXHEALTH) has a ROCE of 14.97%, which is below the benchmark median of 15.77%, a difference of -5.07%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	92,221.1	103.35	5.56	12.95	13.93
Apollo Hospitals Enterprise Ltd.	APOLLOHOSP	1,15,315.29	55.19	11.91	23.54	21.73
Aster DM Healthcare Ltd.	ASTERDM	61,012.71	191.45	14.42	13.07	16.22
Fortis Healthcare Ltd.	FORTIS	59,271.76	56.56	5.83	11.32	14.07
Global Health Ltd.	MEDANTA	35,327.46	63.52	8.59	15.12	19.38

Max Healthcare Institute Ltd. (MAXHEALTH) has a P/E ratio of 59.06x compared with the displayed peer median of 63.52x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.53% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 14.97% versus the displayed peer median of 16.22%, providing a capital-efficiency comparison. Max Healthcare Institute Ltd. (MAXHEALTH) has a market capitalisation of Rs 86,040.63 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching

• The MAXHEALTH 52 Week Low Streak has now run for eight consecutive sessions, keeping the stock in the yearly low zone.
• The cumulative move across the streak is down 9.91%, which makes the repeated weakness more important than one intraday move.
• MAXHEALTH Share Price is still trading at a premium P/E and P/B versus the industry median, so valuation remains part of the discussion.
• The latest Univest reading confirms the pattern, but it does not establish a company-specific cause for the continued decline.
• Investors tracking MAXHEALTH Stock Performance may want to watch whether the price stays anchored near the 52-week trough or moves away from it.

About the Company

Max Healthcare Institute Ltd. is part of the Healthcare sector and the Hospital & Healthcare Services industry. The company is listed on NSE and BSE under MAXHEALTH, and it is one of the larger names in the supplied comparison set by market capitalisation. MAXHEALTH Share Price therefore tends to draw attention not only from readers following hospital operators, but also from those scanning broader Indian healthcare stocks for valuation and operating performance.

For company background, investors generally look at revenue growth, profit growth, return ratios, book value and market capitalisation together. In the current MAXHEALTH Share Price Today context, the repeated-low pattern is the headline point, while the financial snapshot provides the broader frame. The company’s premium valuation means market expectations remain relevant even during a period of weakness. That is why MAXHEALTH Company News and MAXHEALTH Stock News are often read alongside the company’s financial ratios, not separately from them.

From a stock-market research perspective, MAXHEALTH Share Price Update coverage during a MAXHEALTH 52 Week Low Streak helps readers understand whether the low zone is becoming a persistent trading range. It is that repeated pattern, rather than any single intraday print, that defines the current story.

Frequently Asked Questions

Why is MAXHEALTH still trading near its one-year low?

Ans. The latest Univest figures confirm an eighth consecutive session near the 52-week low, but they do not identify a company-specific trigger. The important fact is the persistence of the low zone, not a single-day explanation.

What is the cumulative move across the MAXHEALTH 52 Week Low Streak?

Ans. The stock is down 9.91% across the streak. That cumulative move is the best way to read the repeated weakness because it captures the full stretch, not just one trading day.

Is MAXHEALTH inexpensive compared with healthcare peers?

Ans. Not on the supplied ratios. MAXHEALTH trades at a P/E of 59.06 and a P/B of 7.87, both above the industry medians in the peer set. That means the stock is still valued at a premium.

How does MAXHEALTH compare with other healthcare names?

Ans. In the latest Univest peer set, MAXHEALTH sits below Apollo Hospitals on market capitalisation and above several other names, while its valuation remains richer than the industry median. That makes its repeated low pattern stand out.

What should readers watch next in MAXHEALTH Share Price Today updates?

Ans. Readers should watch whether the stock continues to trade near the 52-week trough or begins moving away from that area. The current story is still one of repeated weakness, not a confirmed change in direction.

Track Max Healthcare Institute Ltd. (MAXHEALTH) Share Price on Univest

Use Max Healthcare Institute Ltd. (MAXHEALTH) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.